• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Thera (NQ: VKTX )

    73.56 +1.02 (+1.40%)
    Streaming Delayed Price Updated: 10:05 AM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Viking Thera

    < Previous 1 2
    ...
    12 13 14 15 16 17 18 19 Next >
    Why Is Viking Therapeutics (VKTX) Stock Moving Today?
    Viking Therapeutics stock is on the move Wednesday as investors react to results from the company's latest clinical trial! 
    Via InvestorPlace
    Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court... 
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
    On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair. 
    Via Benzinga
    Consolidation In Viking Therapeutics Provides An Opportunity
    Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. 
    Via Talk Markets
    2 Magnificient Growth Stocks I'm Buying in August
    These biotech stocks could markedly outperform the broader market. 
    Via The Motley Fool
    9 Analysts Have This to Say About Viking Therapeutics
    Via Benzinga
    Earnings Preview: Viking Therapeutics
    Via Benzinga
    Expert Ratings for Viking Therapeutics
    Via Benzinga
    Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
    U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?
    NASH treatments are projected to be one of the most sought-after indications in the coming years. 
    Via The Motley Fool
    Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
    NASH is a surprisingly common ailment, and the first treatments are on the way. 
    Via The Motley Fool
    The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
    All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
    Via InvestorPlace
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today
    Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study. 
    Via The Motley Fool
    Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush
    A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies. 
    Via MarketBeat
    3 Small-Cap Stocks That Could Be Big-Time Winners
    These stocks come with significant risks. But they could generate huge returns over time. 
    Via The Motley Fool
    The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?
    An overweight world is hungry for new treatments. For now, two companies own the market. 
    Via Investor's Business Daily
    3 Top Biotech Stocks Defying the Bear Market
    Each has the potential to dramatically outperform the market. 
    Via The Motley Fool
    2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher
    Are analysts right to be so bullish about these stocks? 
    Via The Motley Fool
    The 3 Best Momentum Stocks to Buy in July
    For those who identify the right shares at the right time, the rewards of momentum stocks far outstrip those of their competitors. 
    Via InvestorPlace
    The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
    If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead. 
    Via InvestorPlace
    Better Buy: Nano-X Imaging vs. Viking Therapeutics
    Which healthcare stock is the better option for growth investors? 
    Via The Motley Fool
    Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
    Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was... 
    Via Benzinga
    Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
    Via Benzinga
    Why Viking Therapeutics Is Plunging Today
    The biotech's shares are being negatively impacted today by mid-stage data for a competing weight loss drug. 
    Via The Motley Fool
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Viking Therapeutics Stock Is Crashing Today
    Investors seem concerned about the company's competitive positioning in weight loss. 
    Via The Motley Fool
    2 Low-Priced Stocks That Could Make You Richer
    These two low-priced healthcare stocks could skyrocket within the next 12 months. 
    Via The Motley Fool
    3 Biotech Stocks to Buy as Companies Ink Major Deals
    Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy. 
    Via InvestorPlace
    < Previous 1 2
    ...
    12 13 14 15 16 17 18 19 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.